4-125449031-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_001291303.3(FAT4):c.8021A>T(p.Asp2674Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00281 in 1,613,802 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 6 hom. )
Consequence
FAT4
NM_001291303.3 missense
NM_001291303.3 missense
Scores
4
4
11
Clinical Significance
Conservation
PhyloP100: 9.14
Genes affected
FAT4 (HGNC:23109): (FAT atypical cadherin 4) The protein encoded by this gene is a member of the protocadherin family. This gene may play a role in regulating planar cell polarity (PCP). Studies in mice suggest that loss of PCP signaling may cause cystic kidney disease, and mutations in this gene have been associated with Van Maldergem Syndrome 2. Alternatively spliced transcript variants have been noted for this gene. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.08642647).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00187 (284/152214) while in subpopulation NFE AF= 0.00347 (236/68012). AF 95% confidence interval is 0.00311. There are 0 homozygotes in gnomad4. There are 113 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAT4 | NM_001291303.3 | c.8021A>T | p.Asp2674Val | missense_variant | 10/18 | ENST00000394329.9 | NP_001278232.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAT4 | ENST00000394329.9 | c.8021A>T | p.Asp2674Val | missense_variant | 10/18 | 5 | NM_001291303.3 | ENSP00000377862.4 | ||
FAT4 | ENST00000335110.5 | c.2909A>T | p.Asp970Val | missense_variant | 9/15 | 1 | ENSP00000335169.5 | |||
FAT4 | ENST00000674496.2 | c.2792A>T | p.Asp931Val | missense_variant | 9/17 | ENSP00000501473.2 |
Frequencies
GnomAD3 genomes AF: 0.00187 AC: 284AN: 152096Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
284
AN:
152096
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00138 AC: 345AN: 249764Hom.: 0 AF XY: 0.00131 AC XY: 178AN XY: 135400
GnomAD3 exomes
AF:
AC:
345
AN:
249764
Hom.:
AF XY:
AC XY:
178
AN XY:
135400
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00291 AC: 4255AN: 1461588Hom.: 6 Cov.: 41 AF XY: 0.00288 AC XY: 2092AN XY: 727092
GnomAD4 exome
AF:
AC:
4255
AN:
1461588
Hom.:
Cov.:
41
AF XY:
AC XY:
2092
AN XY:
727092
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00187 AC: 284AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.00152 AC XY: 113AN XY: 74458
GnomAD4 genome
AF:
AC:
284
AN:
152214
Hom.:
Cov.:
32
AF XY:
AC XY:
113
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
11
ALSPAC
AF:
AC:
19
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
19
ExAC
AF:
AC:
148
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden | Nov 03, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 14, 2018 | The D2672V variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The D2672V variant is observed in 315/126102 (0.25%) alleles from individuals of European background in large population cohorts (Lek et al., 2016). The D2672V variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. GeneDx interprets D2672V as a variant of uncertain significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 26, 2023 | The FAT4 c.8015A>T; p.Asp2672Val variant (rs138655269), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 420323). This variant is found in the non-Finnish European population with an overall allele frequency of 0.25% (324/128362 alleles) in the Genome Aggregation Database. The aspartate at codon 2672 is highly conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.396). Due to limited information, the clinical significance of the p.Asp2672Val variant is uncertain at this time. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Van Maldergem syndrome 2 Uncertain:2
Uncertain significance, criteria provided, single submitter | research | UNC Molecular Genetics Laboratory, University of North Carolina at Chapel Hill | Mar 01, 2021 | The FAT4 c.8015A>T (p.Asp2672Val) missense variant is located in exon 10, and results in a single amino acid substitution from an aspartic acid to a valine. This variant was detected in the compound heterozygous state in an individual with Van Maldergem syndrome 2; this individual was also reported to have diploid/triploid mosaicism (ClinVar entry from Undiagnosed Diseases Network). The variant was also described in the homozygous state in a 3 year-old male with suspected Van Maldergem syndrome; he also had compound heterozygous variants in CYP21A2 and was diagnosed with congenital adrenal hyperplasia (PMID: 31384091). FAT4 c.8015A>T (p.Asp2672Val) is present in human population databases (allele frequency 383 alleles/281150 total alleles: 0.001). Due to the limited information regarding this variant, it is classified as a VUS. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Undiagnosed Diseases Network, NIH | Nov 16, 2016 | - - |
FAT4-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 02, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at